Vyne Therapeutics Inc. Logo

Vyne Therapeutics Inc.

NASDAQ

Currency in USD
0.5090
-0.41 (-44.85%)

Closed

Jul 24, 2026

Day's Range

0.4700
0.5488

52 wk Range

0.2810
1.59
Loading

Key Statistics

Symbol

VYNE

Name

Vyne Therapeutics Inc.

Currency

USD

Exchange

NASDAQ

High

0.54879999

Low

0.47000000

Open

‪0.4867‬

Last

‪0.5090‬

Market Cap

30.82M

Pe Ratio

‪0.70‬

Volume

2.76M

Average Volume

2.17M

Dividend Yield

‪0.00%‬

Change

-0.41

Percent Change

-44.85

Timestamp

2026-07-24

Close

0.50900000

Today Range Start

‪0.4700‬

Today Range End

‪0.5488‬

52 Week Range Start

‪0.2810‬

52 Week Range End

‪1.59‬

Type

Stocks

Country

United States

Compliance - VYNE - Vyne Therapeutics Inc.

Compliance

Status

NON_COMPLIANT

Report Date

2025-02-17

Business Screen

COMPLIANT

Financial Screen

NON_COMPLIANT

Compliant Revenue

‪97.00%‬

Non Compliant Revenue

‪2.00%‬

Questionable Revenue

‪1.00%‬

Securities To Market Cap Ratio

‪50.00%‬

Debt To Market Cap Ratio

‪90.00%‬

Historical Data - VYNE - Vyne Therapeutics Inc.

Historical Data

TimeOpenHighLowCloseVolume

No data available

Profile - VYNE - Vyne Therapeutics Inc.

Profile

Mic Code

XNCM

Sector

Healthcare

Industry

Biotechnology

Employees

10


Vyne Therapeutics Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative dermatology solutions. Primarily focused on the treatment of skin diseases, Vyne Therapeutics leverages its proprietary technologies to address conditions such as acne and rosacea. The company's commitment to advancing dermatological research is evident in its pipeline of therapeutic products that aim to enhance the care and management of skin conditions. By working closely with healthcare professionals and leveraging partnerships within the pharmaceutical industry, Vyne Therapeutics strives to deliver effective treatment options that improve patient outcomes. As an active participant in the biopharmaceutical market, Vyne Therapeutics plays a critical role in advancing dermatological therapies, contributing to the broader medical and healthcare sectors by providing solutions that benefit consumers and practitioners alike.

Profile Details

Type

Common Stock

Ceo

Mr. David T. Domzalski

Address

P.O. BOX 125

City

Stewartsville

State

NJ

Zip

08886

Country

United States

Phone

800 775 7936

Related news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.
Vyne Therapeutics Inc. (VYNE - NASDAQ) Price Today | UA Finance